title: Designing scaffolds to enhance transplanted myoblast survival and migration.
abstract: Myoblast transplantation is currently limited by poor survival and integration of these cells into host musculature. Transplantation systems that enhance the viability of the cells and induce their outward migration to populate injured muscle may enhance the success of this approach to muscle regeneration. In this study, enriched populations of primary myoblasts were seeded onto delivery vehicles formed from alginate, and the role of vehicle design and local growth factor delivery in cell survival and migration were examined. Only 5 +/- 2.5% of cells seeded into nanoporous alginate gels survived for 24 h and only 4 +/- 0.5% migrated out of the gels. Coupling cell adhesion peptides (G4RGDSP) to the alginate prior to gelling slightly increased the viability of cells within the scaffold to 16 +/- 1.4% and outward migration to 6 +/- 1%. However, processing peptide-modified alginate gels to yield macroporous scaffolds, in combination with sustained delivery of HGF and FGF2 from the material, dramatically increased the viability of seeded cells over a 5-day time course and increased outward migration to 110 +/- 12%. This data indicate long-term survival and migration of myoblasts placed within polymeric delivery vehicles can be greatly increased by appropriate scaffold composition, architecture, and growth factor delivery. This system may be particularly useful in the regeneration of muscle tissue and be broadly useful in the regeneration of other tissues as well.
authors.affiliation: Department of Biologic and Material Sciences, University of Michigan, Ann Arbor, Michigan, USA.
authors.forename: Elliott
authors.initials: E
authors.lastname: Hill
authors.forename: Tanyarut
authors.initials: T
authors.lastname: Boontheekul
authors.forename: David J
authors.initials: DJ
authors.lastname: Mooney
mesh_terms: D000464:Alginates; D000818:Animals; D001672:Biocompatible Materials; D002465:Cell Movement; D002470:Cell Survival; D016222:Fibroblast Growth Factor 2; D005782:Gels; D020723:Glucuronic Acid; D017228:Hepatocyte Growth Factor; D006603:Hexuronic Acids; D006801:Humans; D051379:Mice; D018482:Muscle, Skeletal / Q000166:cytology / Q000293:injuries; D032448:Myoblasts, Skeletal / Q000166:cytology / Q000378:metabolism / Q000637:transplantation*; D009842:Oligopeptides; D012038:Regeneration; D023822:Tissue Engineering
chemical_list: D000464:Alginates; D001672:Biocompatible Materials; D005782:Gels; C066855:HGF protein, human; D006603:Hexuronic Acids; D009842:Oligopeptides; D016222:Fibroblast Growth Factor 2; D017228:Hepatocyte Growth Factor; D020723:Glucuronic Acid